Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2017

Pharma News, 2017

FDA accepts BLA for review of what could be first new antiretroviral in 10 years
FDA accepts BLA for review of what could be first new antiretroviral in 10 years
The US Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for ibalizumab as a treatment for multidrug resistant human immunodeficiency v...
Maximum human lifespan could far exceed 115 years – new research
Maximum human lifespan could far exceed 115 years – new research
Five research teams say there is no compelling evidence there is an upper limit on mortality, disputing claim in NatureThe latest research comes in response to a recent high-profile paper that conclud...
More Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention
More Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention
WASHINGTON, D.
FDA allows marketing of test to aid in the detection of certain leukemias and lymphomas
FDA allows marketing of test to aid in the detection of certain leukemias and lymphomas
The U.
Human enzyme may help find cure for Alzheimer's disease
Human enzyme may help find cure for Alzheimer's disease
New York.
Teva introduces generic Trilafon
Teva introduces generic Trilafon
NORTH WALES, Penn.
Over-the-counter magnesium tablets can banish the blues in just TWO WEEKS without the side effects associated with antidepressants
Over-the-counter magnesium tablets can banish the blues in just TWO WEEKS without the side effects associated with antidepressants
Over-the-counter magnesium tablets significantly improve depression in just two weeks, new research reveals.
FDA unveils plan to eliminate orphan designation backlog
FDA unveils plan to eliminate orphan designation backlog
Today, the U.
FDA Tackles Drug Competition to Improve Patient Access
FDA Tackles Drug Competition to Improve Patient Access
Today, the U.
Eyeing a $6B market, Bavarian Nordic posts positive phase 2 data for universal RSV vaccine
Eyeing a $6B market, Bavarian Nordic posts positive phase 2 data for universal RSV vaccine
Chasing a big market opportunity that recently tripped up another vaccine developer, Bavarian Nordic reports that a single shot of its universal respiratory syncytial virus (RSV) candidate can...
U.S. FDA Approves Bevyxxa® (betrixaban) First and Only Anticoagulant for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients
U.S. FDA Approves Bevyxxa® (betrixaban) First and Only Anticoagulant for Hospital and Extended Duration Prevention of Venous Thromboembolism (VTE) in Acutely Ill Medical Patients
SOUTH SAN FRANCISCO, Calif.
Bain, Cinven discussing new offer for Stada: sources
Bain, Cinven discussing new offer for Stada: sources
Buyout groups Bain Capital and Cinven are talking to investors about a potential new offer for German generic drugmaker Stada (STAGn.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand